X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/healthbioai-announces-the-acceptance-by-the-federal-drug-administration-fda-to-proceed-with-a-randomized-clinical-trial-for-the-treatment-of-long-covidpost-acute-sequelae-of-covid-pasc-with-selzentry-maraviroc-in-combinati-302063138.html
https://www.fiercepharma.com/pharma/pfizer-walks-away-over-decade-lipitor-antitrust-litigation-93m-settlement
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214513
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217634
https://www.prnewswire.com/news-releases/cmp-pharma-inc-announces-that-atorvaliq-the-first-and-only-fda-approved-liquid-suspension-of-atorvastatin-is-now-available-301858707.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216436
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-rosemont-pharmaceuticals-ltd-atorvastatin-4mg-slash-ml-oral-suspension-and-sildenafil-10mg-slash-ml-oral-suspension-el-22-a-slash-39
https://recalls-rappels.canada.ca/en/alert-recall/jamp-atorvastatin-calcium-affected-lot-may-be-labelled-incorrect-strength-label
https://recalls-rappels.canada.ca/en/alert-recall/jamp-atorvastatin-affected-lot-may-contain-latex
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214969
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214659
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-23-2021-1624432636.pdf
https://www.moneycontrol.com/news/business/dr-reddys-recalls-2980-bottles-of-cholesterol-lowering-drug-in-us-6994171.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-2-2021-1622637119.pdf
https://www.fiercepharma.com/manufacturing/dr-reddy-s-pulls-hundreds-thousands-bottles-lipitor-generic-over-impurity-fears
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-10-2021-1615353629.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213853
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-25-2020-1585131468.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2020-1582176609.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-12-2020-1581485052.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205945
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-6-2019-1573017375.pdf
https://www.cnbc.com/2019/11/05/reuters-america-update-3-mylan-shares-slide-after-warning-of-hit-to-revenue.html
https://endpts.com/the-top-10-franchise-drugs-in-biopharma-history-will-earn-a-total-of-1-4t-trillion-by-2024-what-does-that-tell-us/
https://www.fiercepharma.com/pharma/top-10-all-time-biggest-selling-drugs-by-2024
https://www.fiercepharma.com/pharma/pfizer-could-merge-off-patent-drug-business-mylan-and-analysts-already-like-sound-it
https://www.fiercepharma.com/pharma/lyrica-generics-roll-pfizer-finally-hits-patent-cliff-for-nerve-pain-and-fibromyalgia
https://www.raps.org/news-and-articles/news-articles/2019/7/fda-approves-first-lyrica-generics-from-9-sponsors
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208478
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-big-pharma-s-chinese-q1-pfizer-upjohn-new-hq-hansoh-s-1b-hk-ipo
https://www.businesswire.com/news/home/20190430005302/en/Merck-Announces-First-Quarter-2019-Financial-Results/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.bloomberg.com/news/features/2019-01-31/culture-of-bending-rules-in-india-challenges-u-s-drug-agency
https://www.biospace.com/article/pfizer-s-cancer-portfolio-expected-to-rake-in-8-3-billion-in-2019/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-receives-final-approvals-from-usfda-for-skin-ointment-heart-medicine/articleshow/67499638.cms
https://www.bloomberg.com/news/articles/2019-01-03/trump-s-fda-might-greenlight-drug-prescribing-apps-for-chronic-ailments
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209288
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-generic-cholesterol-drug/66751097
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206536
https://www.biopharmadive.com/news/drug-ads-tv-pharma-changing-face-dtc-advertising/539982/
https://www.reuters.com/article/us-australia-pfizer/australian-watchdogs-appeal-against-pfizer-ruling-dismissed-by-court-idUSKCN1MT07B
https://www.fiercepharma.com/pharma/ceo-ian-read-hands-reins-a-slimmer-sleeker-pfizer-to-coo-albert-bourla
https://seekingalpha.com/article/4207139-pfizer-conatus-emricasan-nash
https://www.fiercepharma.com/pharma/cardiovascular-landscape-from-2017-to-2024-featuring-eliquis-xarelto-and-more
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-22-2018-1534903909.pdf
https://www.marketwatch.com/story/doctor-payments-increased-drug-prescribing-by-73-new-study-finds-2018-07-30
https://www.fiercepharma.com/pharma/pfizer-s-new-structure-for-growth-but-don-t-count-out-future-splits-execs
Market Place
Share 
